We have a firm 3-page limit for the statement. It has been reviewed by the
Divisions and Drs. Harper, Eisinger, Lerner, and Marston, as well as Courtney
Billet, Martin Johnson, Greg Folkers, and Laurie Doepel.

NIH OLPA has asked to receive your statement by this Wednesday, Feb. 19th.
Please let us know if you would like us to request additional time for your review,
given competing priorities.

Thank you for your help.

Sara

Sara Selgrade, Ph.D.

Section Chief for Legislative Activities

Legislative Affairs and Correspondence Management Branch
Office of Communications and Government Relations
NIAID/NIH/DHHS

Bidg. 31. Room 7A17, MSC 2520

Bethesda, MD 20892-2520

Phone:

   

Disclaimer:

The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not be
used hy anyone who ts not the original intended recipient. If vou have received this e-mail in error please inform the sender and
delete it from vour mailbox or any other Storage devices. National Institute of Allergy and Infectious Diseases shall not accept
liability for any statements made that are sender's own and not expressly made on behalf of the NEAID hy one of its
representatives,

NIH-001779
